Financial Summary (All financials)
| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 |
| Revenues | 0.0 | 0.0 | 0.2 |
| Revenue growth | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.2 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Gross margin | | | -15.6% |
| Research and development | 3.0 | 2.3 | |
| General and administrative | 3.9 | 1.3 | 0.0 |
| EBIT | -6.8 | -3.6 | -0.2 |
| EBIT margin | | | -115.6% |
| Pre-tax income | -6.8 | -30.3 | -0.2 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -6.8 | -38.5 | -0.2 |
| Net margin | | | -116.4% |
| |
| Diluted EPS | ($0.29) | ($2.83) | ($0.01) |
| Shares outstanding (diluted) | 23.3 | 13.6 | 12.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|